The ability of a killed phase I Coxiella burnetii vaccine to induce cell-mediated immune responses in guinea pigs was studied. Cell-mediated immune responses were assessed by the inhibition of macrophage migration and lymphocyte transformation assays. The macrophage migration response occurred rapidly and was detected at high levels, but was relatively short-lived. In contrast, the lymphocyte transfornation response developed more slowly, and persisted for a longer period. The vaccine, given in a single dose or in two doses 1 week apart, protected guinea pigs from a subsequent virulent challenge.
Vaccines made from killed Coxiella burnetii have been shown to be effective in eliciting humoral antibodies in humans and guinea pigs (21) . The protective efficacy of the vaccine has been demonstrated in humans and guinea pigs (2, 15, 23) . Early Q fever vaccines were prepared from strains of C. burnetii predominantly in phase II; however, studies by Ormsbee et al. (18) showed that formalin-killed phase I rickettsiae possessed protective potencies 100 to 300 times greater than phase II organisms. Recent studies indicate that cell-mediated immunity also may play a role in the defense against C. burnetii infection. Peritoneal macrophages from guinea pigs vaccinated with Formalin-killed phase I rickettsiae are capable of killing ingested phase I rickettsiae in vitro in the absence of immune serum (12, 13) . This activity is demonstrable at a time when macrophage inhibition factor is present in the peritoneal cavity (12) . In guinea pigs infected with phase I C. burnetii, inhibition of macrophage migration (IMM) was noted as early as 3 days postchallenge and reached maximum levels between 14 
RESULTS
After vaccination of guinea pigs with the Formalin-killed, particulate, phase I Q fever vaccine, the temporal development of humoral antibody and cell-mediated immune responses was studied. The time of appearance and the persistence of humoral and cellular responses were dependent upon the vaccination regimen. The IMM responses of guinea pigs given vaccine in a single dose are shown in Fig. 1 by day 21 (Fig. 1) . Antibody to phase I antigen was not detected when assayed by two additional serological assays, the complement fixation (4) and microagglutination (7) tests (data not shown).
Guinea pigs responded to the two-dose vaccine regimen with enhanced cellular and humoral responses, as compared with those given a single dose. On day 7 after administration of the second dose, IMM was approximately 70% in cultures with either antigen (Fig. 2) . Inhibition decreased thereafter, but remained demonstrable for 28 days, compared with a 14-day duration after the single-dose schedule. Likewise, antibody production was also potentiated with the two-dose regimen. Phase II antibody was detected after 7 days, and phase I antibody was detected on day 21 (Fig. 2) .
The humoral and cellular responses were also determined in guinea pigs vaccinated once with the vaccine emulsified in an equal volume of IFA. These anils demonstrated IMM and humoral antibody responses similar to those animals given two doses of the vaccine a week apart (data not shown).
LT. Antigen-specific responsiveness of peripheral leukocytes from vaccinated guinea pigs was evaluated with the LT test. These responses were measured on the same animal at weekly intervals. Animals inoculated with a single dose of vaccine developed a relatively low, delayed LT response; the stimulation index did not differ from base line on day 7 significantly on day 21 and persisted at an elevated level until day 35 (Fig. 3) . In contrast, with the group vaccinated on the two-dose schedule, rickettsial antigens failed to stimulate a proliferative response at any time during the 42-day experimental period (data not shown).
Additional studies were performed with a group of animals immunized with vaccine in IFA. These guinea pigs demonstrated markedly enhanced leukocyte responsiveness. The response was minimal at 7 days (Fig. 3) (Fig. 3) . Unlike the significant increase in the IMM responses, there was no significant elevation in the stimulation index up to 14 days after challenge (data not shown).
DISCUSSION
Guinea pigs vaccinated subcutaneously with Formalin-killed, particulate, phase I C. burnetii developed a cell-mediated immune response as measured by two different in vitro assays. The IMM activity was demonstrable at very high levels within 1 week after vaccination, but was relatively short-lived. This response to subcutaneous vaccination is similar to that observed in guinea pigs after infection with virulent phase I C. burnetii by the respiratory route (11) .
The temporal course of the antigen-specific response as measured by the LT test did not correlate with IMM. After one dose of vaccine, LT response developed more slowly than IMM, but persisted at low levels for a longer period; sensitized populations oflymphocytes were present in peripheral circulation 35 days after vaccination. After two doses of vaccine, the blastogenic response failed to be detectable, although IMM reactivity was markedly enhanced. The hypothesis put forth by Oppenheim (17) explains this lack of response as caused by antigenantibody complexes formed in antibody excess; Lee and Sigel (14) suggest that antigens complexed with immunoglobulin M antibodies can depress lymphocyte stimulation, with the same result. The observation that antibody to phase I antigen was present in guinea pigs that received two doses of vaccine, but not in those that received one dose, would seem to agree with this hypothesis. However, although antibody titers for guinea pigs that were inoculated with one dose of the vaccine suspended in IFA were similar to those for the two-dose group, the blastogenic response after vaccine in IFA was remarkably enhanced. This suggests that the lack of stimulation index response for the two-dose regimen was not due wholly to antibody suppression.
The ability of killed rickettsial vaccines to induce a cellular immune response has been noted by others. Coonrod and Shepard (5) The present studies indicate a possible role for cell-mediated immunity in protection. Guinea pigs vaccinated with one dose of the vaccine produced no detectable serum antibody (by microagglutination, complement fixation, and indirect immunofluorescence), but developed antigen-specific lymphocyte responsiveness. Suggestive evidence for a role for cell-mediated immunity in resistance to infection with C. burnetii was described in our previous studies (12, 13) , in which macrophages from guinea pigs vaccinated with a phase I Formalin-killed antigen were capable of destroying phase I rickettsiae in the absence of immune serum. Likewise, Benenson (2) showed that, whereas only 50% of human volunteers vaccinated with killed phase I antigen developed detectable antibody, all were resistant to aerosol challenge with virulent rickettsiae.
The role of lymphokines, such as the macrophage inhibition and blastogenic factors, in the pathogensis of, and/or host defense against, Q fever infections is not known. Enhancement of antigen-specific blastogenic responses could result in an increased production of functional T and B lymphocytes and/or in stimulated production of lymphokines or antibodies capable of affecting host resistance in a variety of ways. It has been suggested by other investigators that macrophage inhibition factor not only localizes macrophages at the site of infection, but also participates in the activation of macrophage; phagocytic, bacteriostatic, and even bactericidal activities of macrophages are enhanced in the 197 VOL. 19, 1978 on October 26, 2017 by guest http://iai.asm.org/ presence of either sensitized lymphocytes or their soluble products (8, 16, 20) . Studies by Hinrichs and Jerrells (9) provide evidence that normal guinea pig peritoneal macrophages cultured in vitro with immune lymphocytes or with macrophage inhibition factor-rich supernatant fluid inhibit the growth of ingested C. burnetii.
Our data suggesting a role for cell-mediated immunity do not eliminate a contributory role for humoral antibody in the overall defense of the host. Serum antibodies for phase II antigen were present at high levels in those guinea pigs given two doses of the vaccine, and antibodies against phase I antigen rapidly increased in vaccinated animals after challenge. In our previous studies, pretreatment ofrickettsiae with immune serum not only enhanced ingestion of organisms within the phagocyte but also potentiated the destruction of ingested organisms (12, 13) . Moreover, while immune serum is not known to have a direct rickettsicidal effect on C. burnetii, rickettsiae incubated with specific antiserum before inoculation do not cause infection in guinea pigs (1) . The rapid mobilization of both humoral and cellular responses after challenge of vaccinated guinea pigs suggests that both facets of immune activity participate in defense against Q fever infection. Further work is needed to define the specific contribution of humoral and cellular immune responses in protection.
